Is NTR a Buy or a Sell? The Bull and Bear Case (2026)
Last updated July 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Nutrien (NTR) rests on Potash pricing and record volumes: Potash is Nutrien's highest-margin upstream nutrient, and the company is the world's largest producer. The bear case rests on the dominant risk is commodity price cyclicality: potash, nitrogen and phosphate prices can fall sharply, and because upstream margins are highly operationally geared, consolidated earnings can drop far faster than revenue. Analysts covering it publish targets from $59.00 to $90.00 against a $70.05 price, so even the professionals disagree by 40% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
Nutrien is a Canadian-headquartered agricultural giant formed from the 2018 merger of Potash Corp and Agrium, and it reports in U.S. dollars. The company runs four segments: Retail (Nutrien Ag Solutions), which distributes crop nutrients, crop protection, seed and services to farmers through a large network of stores across North America, South America and Australia, plus three upstream segments (Potash, Nitrogen and Phosphate) that mine and manufacture the fertilizers themselves. Nutrien is the largest potash producer in the world by capacity and one of the largest nitrogen producers, so its upstream results move directly with global fertilizer benchmarks, while Retail earns more stable margins from proprietary products and services. The investment picture is a blend of commodity cyclicality and defensive scale. When potash and nitrogen prices are firm, as they were through 2025 and into 2026, the upstream segments throw off large cash flows and consolidated earnings jump. When prices fall, upstream profits compress quickly, and the Retail arm plus the dividend become the ballast. Nutrien has leaned into shareholder returns (a growing dividend and share buybacks) and cost discipline, framing itself as a lower-volatility way to own the crop-inputs theme than the pure-play miners or nitrogen producers.
The bull case: what would have to be true for $90.00
The most optimistic published target on NTR is $90.00, +28.5% from the $70.05 price as of July 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Potash pricing and record volumes
Potash is Nutrien's highest-margin upstream nutrient, and the company is the world's largest producer. Through 2025 and into Q1 2026 it delivered record potash sales volumes at higher global benchmark prices, with potash adjusted EBITDA of ~$578 million in Q1 2026 alone. Because Nutrien has low-cost Saskatchewan mines and can flex volume, the potash cycle is the single biggest swing factor in its earnings.
2. Nitrogen leverage to natural gas
Nitrogen fertilizer (ammonia, urea) is made from natural gas, so Nutrien's North American plants benefit from relatively cheap U.S. gas versus European rivals whose costs track higher gas prices. Higher nitrogen selling prices and volumes lifted the segment in 2025, and management is expanding upstream fertilizer volumes from North American plants as a 2026 growth driver.
3. Retail as the steady cash engine
Nutrien Ag Solutions is the largest ag-retail network in the Americas and generates more stable, less commodity-linked margins from proprietary products, seed, crop protection and services. Management guides Retail adjusted EBITDA to ~$1.75 to $1.95 billion for 2026 and treats it as structural growth that smooths the upstream cycle.
4. Capital returns and cost discipline
Nutrien pays a US$2.20 annualized dividend (about a 3% yield) and runs a normal course issuer bid to buy back up to 5% of shares, repurchasing roughly 2% in 2025 for ~$551 million. Alongside cost-savings initiatives in Retail, the capital-return program is a core part of the story for holders who want cash back through the cycle.
The bear case: what would have to be true for $59.00
The most pessimistic published target is $59.00, -15.8% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Nutrien is worth if the risks below bite instead of the drivers above.
The dominant risk is commodity price cyclicality: potash, nitrogen and phosphate prices can fall sharply, and because upstream margins are highly operationally geared, consolidated earnings can drop far faster than revenue. Natural gas cost spikes would squeeze nitrogen margins, and weather, crop prices and farmer income drive demand for both fertilizer and Retail products in ways Nutrien cannot control. Geopolitics matters heavily, since sanctions, tariffs and shifts in Russian and Belarusian potash supply move global benchmarks. Foreign-exchange swings (the company operates globally but reports in USD) and heavy capital spending on mines and plants add further variability. Finally, the fertilizer industry is concentrated and has faced antitrust and price-fixing litigation, an overhang for the whole peer group.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding NTR already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on NTR
21 analysts cover NTR, with an average target of $77.97 (+11.3% against $70.05) and a split of 17 buy, 5 hold, 2 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the NTR forecast and price target page.
How is NTR valued? (as of JULY 2026)
Snapshot for NTR as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Share price: ~$66
- Market cap: ~$32 billion
- Revenue (TTM): ~$28 billion
- FY2025 net earnings: ~$2.3 billion
- FY2025 adjusted EBITDA: ~$6.05 billion
- Dividend / yield: ~$2.20 per share (~3.3%)
As of July 2026 NTR trades near $66 for a market cap of roughly $32 billion, at a trailing P/E around 16 and a forward P/E near 15.5, modest multiples typical of a cyclical commodity producer. Q1 2026 revenue was ~$6.0 billion (up ~19% year over year) with adjusted EBITDA of ~$1.11 billion, and the business is seasonal, with the spring planting quarter usually the strongest. Because so much of the profit is commodity-driven, valuation multiples on trailing earnings can look cheap near cycle peaks and expensive near troughs, so context on where fertilizer prices sit matters more than the headline P/E.
How do you decide if NTR is a buy?
Rather than asking whether NTR is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold NTR indirectly through an index or sector ETF before adding more.
What would change your mind on NTR
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Potash pricing and record volumes stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: the dominant risk is commodity price cyclicality: potash, nitrogen and phosphate prices can fall sharply, and because upstream margins are highly operationally geared, consolidated earnings can drop far faster than revenue fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the NTR stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about NTR against your real portfolio and see your actual exposure before deciding.
Investing in Nutrien with AI
Connect the broker you already use and ask Walnut's AI how NTR fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is NTR a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Potash pricing and record volumes, with revenue (ttm) at ~$28 billion. The bear case rests on the dominant risk is commodity price cyclicality: potash, nitrogen and phosphate prices can fall sharply, and because upstream margins are highly operationally geared, consolidated earnings can drop far faster than revenue. Analysts covering it are spread from $59.00 to $90.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell NTR?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The dominant risk is commodity price cyclicality: potash, nitrogen and phosphate prices can fall sharply, and because upstream margins are highly operationally geared, consolidated earnings can drop far faster than revenue. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $59.00, -15.8% from the $70.05 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for NTR?
+
Potash pricing and record volumes. Potash is Nutrien's highest-margin upstream nutrient, and the company is the world's largest producer. The most optimistic analyst target on NTR is $90.00, +28.5% from the $70.05 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for NTR?
+
The dominant risk is commodity price cyclicality: potash, nitrogen and phosphate prices can fall sharply, and because upstream margins are highly operationally geared, consolidated earnings can drop far faster than revenue. Natural gas cost spikes would squeeze nitrogen margins, and weather, crop prices and farmer income drive demand for both fertilizer and Retail products in ways Nutrien cannot control. Geopolitics matters heavily, since sanctions, tariffs and shifts in Russian and Belarusian potash supply move global benchmarks. Foreign-exchange swings (the company operates globally but reports in USD) and heavy capital spending on mines and plants add further variability. Finally, the fertilizer industry is concentrated and has faced antitrust and price-fixing litigation, an overhang for the whole peer group. The most pessimistic published target is $59.00, -15.8% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does Nutrien do?
+
Nutrien is a Canadian-headquartered agricultural giant formed from the 2018 merger of Potash Corp and Agrium, and it reports in U.S.
What would have to change for NTR to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Potash pricing and record volumes) stalling in the reported numbers rather than in the narrative, the risk above (the dominant risk is commodity price cyclicality: potash, nitrogen and phosphate prices can fall sharply, and because upstream margins are highly operationally geared, consolidated earnings can drop far faster than revenue) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does Nutrien actually do?
+
Nutrien is the world's largest crop-inputs company. It mines and manufactures fertilizer (potash, nitrogen and phosphate) through its upstream segments, and it distributes crop nutrients, crop protection, seed and agronomic services to farmers through Nutrien Ag Solutions, the largest ag-retail network in the Americas.
Is NTR a good investment?
+
Walnut is not an investment adviser and cannot tell you whether to buy NTR. The bull case is a low-cost global fertilizer leader with a large stable Retail arm, a ~3% dividend and buybacks, trading at modest multiples. The bear case is deep commodity cyclicality: potash and nitrogen prices can fall fast and take earnings with them, and demand depends on weather, crop prices and geopolitics. How you weigh those depends on your own goals and risk tolerance.
Does Nutrien pay a dividend?
+
Yes. Nutrien pays a US$0.55 quarterly dividend, or US$2.20 annualized, which works out to roughly a 3.3% yield at a mid-2026 share price near $66. The company has generally raised the dividend over time and also buys back stock, returning cash through the commodity cycle.
Walnut is informational, not investment advice, and gives no verdict on NTR. Analyst targets referenced here come from a July 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.
Guides that feature NTR
NTR is one of the names covered in these guides. Each one puts the stock next to its peers so you can see where it fits rather than judging it alone.